WallStreetZenWallStreetZen

NASDAQ: LAB
Standard Biotools Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Standard Biotools earnings were $78.2M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest LAB earnings report on Mar 31, 2026 announced Q1 2026 earnings of $127.1M, up 559% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, LAB reported annual earnings of -$74.9M, with -59.5% growth.

LAB earnings history

Current Revenue
$86.3M
Current Earnings
$78.2M
Current Profit Margin
90.7%

LAB Return on Equity

Current Company
17.3%
Current Industry
-11.3%
Current Market
14%
LAB's Return on Equity (17.3%)... subscribe to Premium to read more.
High Return on Equity Performance

LAB Return on Assets

Current Company
13.6%
Current Industry
6.4%
LAB is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LAB announces earnings.

LAB Return on Capital Employed

Current Company
6.78%
Current Industry
13.2%
LAB has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LAB vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LAB$54.63M$78.21MN/A$0.20
MYGN-$328.30M-$399.90MN/A-$4.29
FLGT-$57.01M-$73.81MN/A-$2.39
PRE-$33.89M-$37.71MN/A-$2.68
IMDX-$45.40M-$47.84MN/A-$1.50
View Top Diagnostic & Research Stocks

Standard Biotools Earnings Reports & History FAQ

What were Standard Biotools's earnings last quarter?

On LAB's earnings call on Invalid Date, Standard Biotools (NASDAQ: LAB) reported Q1 2026 earnings per share (EPS) of $0.33, up 571.43% year over year. Total LAB earnings for the quarter were $127.07 million. In the same quarter last year, Standard Biotools's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Standard Biotools stock.

Is Standard Biotools profitable or losing money?

As of the last Standard Biotools earnings report, Standard Biotools is currently profitable. Standard Biotools's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $78.21 million, a 158.91% decrease year over year.

What was LAB's earnings growth in the past year?

As of Standard Biotools's earnings date in Invalid Date, Standard Biotools's earnings has grown year over year. LAB earnings in the past year totalled $78.21 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.